{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-078581","form_type":"8-K","ticker":"CERT","cik":"0001827090","company_name":"Certara, Inc.","filed_at":"2024-07-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.743394+00:00","generated_at":"2026-05-31T22:38:50.244834+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Certara signs definitive agreement to acquire Chemaxon; reiterates 2024 guidance","bullets":["Definitive agreement to acquire Chemaxon, a cheminformatics software provider; no deal value disclosed.","Transaction expected to close in H2 2024, subject to regulatory approval and customary conditions.","Chemaxon expected to generate >$20M software revenue in 2024; adjusted EBITDA margin near Certara's corporate average by end 2025.","Certara reiterates 2024 revenue, adjusted EBITDA margin (31-33%), and adjusted diluted EPS guidance from May 7 earnings call.","Acquisition expands Certara's drug discovery biosimulation portfolio; long-term partnership with Chemaxon."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-078581","json":"https://secwatch.observer/filing/0001104659-24-078581.json","markdown":"https://secwatch.observer/filing/0001104659-24-078581.md","text":"https://secwatch.observer/filing/0001104659-24-078581.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1827090/000110465924078581/0001104659-24-078581-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1827090/000110465924078581/tm2418257d3_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T22:38:50.244834+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}